Dr. Gaudinski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Center Dr
Building 10 Room 52448
Bethesda, MD 20814Phone+1 301-761-7094Fax+1 877-303-1460
Education & Training
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2011 - 2014
Georgetown University School of MedicineClass of 2011
Certifications & Licensure
MD State Medical License 2012 - 2026
DC State Medical License 2011 - 2024
VA State Medical License 2011 - 2016- American Board of Allergy and Immunology Allergy & Immunology
Clinical Trials
- Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-EBOMAB092-00-AB (MAb114), Administered Intravenously to Healthy Adults Start of enrollment: 2018 May 16
- Phase I, Open-Label, Dose-Escalation Study of a Human Monoclonal Antibody, VRC-HIVMAB091-00-AB (N6LS), Administered Intravenously or Subcutaneously With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20) Start of enrollment: 2018 Jun 21
- Phase I Study to Evaluate a Human Monoclonal Antibody (MAb) 10E8VLS Administered Alone or Concurrently With MAb VRC07-523LS Via Subcutaneous Injection in Healthy Adults Start of enrollment: 2018 Jul 10
Publications & Presentations
PubMed
- 11 citationsSafety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-hum...Melinda J Hamer, Katherine V Houser, Amelia R Hofstetter, Ana M Ortega-Villa, Christine Lee
Lancet. 2023-01-28 - 155 citationsSafety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults.Martin R. Gaudinski, Emily E. Coates, Katherine V. Houser, Grace L. Chen, Galina Yamshchikov
Plos Medicine. 2018-01-24 - 38 citationsSafety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation cli...Tracy J. Ruckwardt, Kaitlyn M. Morabito, Emily Phung, Michelle C. Crank, Pamela Costner
The Lancet. Respiratory Medicine. 2021-10-01
Press Mentions
Monoclonal Antibody Prevents Malaria in Small NIH TrialAugust 13th, 2021- New Mechanism Meditates Link Between Fetal Conditions and Later HealthAugust 10th, 2021
First Human Trial of Monoclonal Antibody to Prevent Malaria OpensJanuary 29th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
